ImmunoPrecise AntibodiesIPA 
$0.6613.99%24h
13.99%24h
Global rank30690
Market cap$16.43M
Change 7d13.79%
YTD Performance-59.51%
SP500 benchmarkUnderperform
P/E-0.62
P/S1.08
Revenue$15.18M
Earnings-$19.51M
Dividend yield-
ImmunoPrecise Antibodies IPA Total Debt
IPA Total Debt in 2022: $4.52M
According to ImmunoPrecise Antibodies latest financial reports the total debt is $4.52M, an increase of 1214.32% to 2022. At the end of 2022 company had $343.75K total debt. This figure represents the debts and financial obligations that ImmunoPrecise Antibodies combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
ImmunoPrecise Antibodies IPA Total Debt History from 2023 to 2022
-
Value:-
IPA Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $4.52M | 1214.32% |
| 2022 | $343.75K | -81.06% |
| 2021 | $1.81M | 51.13% |
| 2020 | $1.20M | 1534.40% |
| 2019 | $73.48K | - |
View the Top Total Debt Stocks 
